Do we need new antibiotics? The search for new targets and new compounds

Journal of Industrial Microbiology and Biotechnology

Volumn 37, Issue 12, 2010, Pages 1241-1248

  Spížek, Jaroslav ^a   Novotná, Jitka ^a,c   Řezanka, Tomáš ^a   Demain, Arnold L ^b  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b DREW UNIVERSITY   (United States)

^c CROP RESEARCH INSTITUTE   (Czech Republic)

Author keywords

Antibiotic resistance; Antibiotics; Biosynthesis; Infectious diseases; Search for new compounds

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ANTIBIOTIC AGENT; FATTY ACID; FOLIC ACID; LIPID A; NATURAL PRODUCT; PEPTIDE DEFORMYLASE INHIBITOR; PEPTIDOGLYCAN; POLYKETIDE SYNTHASE; TEICHOIC ACID;

ANTIBIOTIC RESISTANCE; ASPERGILLUS NIDULANS; BACTERIAL STRAIN; BACTERIOPHAGE; BIOSYNTHESIS; BIOTRANSFORMATION; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CHIRALITY; CONFERENCE PAPER; DNA DETERMINATION; DRUG TARGETING; ENTEROCOCCUS FAECALIS; GENE CLUSTER; GENE SEQUENCE; GENETIC CODE; METAGENOMICS; MICROBIAL GENETICS; NONHUMAN; PROTEIN SECRETION; STREPTOMYCES COELICOLOR; STREPTOMYCES GRISEUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BIOLOGICAL PRODUCTS; DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; METAGENOMICS;

BACTERIA (MICROORGANISMS);

EID: 78651269003     PISSN: 13675435     EISSN: 14765535     Source Type: Journal    
DOI: 10.1007/s10295-010-0849-8     Document Type: Conference Paper

References (50)

1. Alanis AJ (2005) Resistance to antibiotics: are we in the postantibiotic era? Arch Med Res 35:607-705
2. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J (2010) Call of the wild: antibiotic resistance genes in natural environment. Nat Rev Microbiol 8:251-259
3. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8:260-271
4. Ansorge WJ (2009) Next-generation DNA sequencing techniques. New Biotechnol 25:195-203
5. Baltz RH (2007) Antimicrobials from actinomycetes: back to the future. Microbe 2:125-131
6. Baltz RH (2008) Renaissance in antibacterial discovery from actinomycetes. Curr Opinion Pharmacol 8:557-563
7. Bentley SD, Chater KF, Cerdeño-Tárraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra CW, Chen CW, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Server K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3 (2). Nature 417:141-147 (Pubitemid 34506788)
8. Bergmann S, Schümann J, Scherlach K, Lange C, Brakhage AA, Hertweck C (2007) Genomics driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat Chem Biol 3:213-217
9. Borman S (2002) Organic lab sparks drug discovery. Chem Eng News 80(2):23-24
10. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PloS Pathog 3:168-178
11. Breinbauer R, Manger M, Scheck M, Waldmann H (2002) Natural product guided compound library development. Curr Med Chem 9:2129-2145
12. Bibb M, Hesketh A (2009) Analyzing the regulation of antibiotic production in streptomycetes. Methods Enzymol 458:93-116
13. Brown ED, Wright DW (2005) New targets and screening approaches in antimicrobial drug discovery. Chem Rev 105:759-774
14. Champney WS (2008) New antibiotic targets (methods in molecular biology). Humana, Totowa, New Jersey, USA
15. Daniel R (2005) The soil metagenome-a rich resource for the discovery of novel natural products. Curr Opin Biotechnol 15:199-204
16. Davies J (2007) Microbes have the last word. A drastic re-evaluation of antimicrobial treatment is needed to overcome the threat of antibiotic resistant bacteria. EMBO Rep 8:616-621
17. Demain AL, Sanchez S (2009) Microbial drug discovery: 80 years of progress. J Antibiot 62:5-16
18. Feher M, Schmidt JM (2003) Property distributions: differences between drug, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43:218-227
19. Fenical W, Jensen PR (2006) Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2:666-673
20. Flicek P, Birney E (2009) Sense from sequence reads: methods for aligment and assembly. Nat Methods 6: S6-S12
21. Hancock R E W (2007) The end of an era. Nat Rev Drug Discov 6:489-497
22. Hopwood DA (2006) Soil to genomics: the Streptomyces chromosome. Ann Rev Genet 40:1-23
23. Hopwood DA (2007) How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them. Mol Microbiol 63:937-940
24. Hopwood DA (2007) Therapeutic treasures from the deep. Nat Chem Biol 3:457-458
25. Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, Shiba T, Sakaki Y, Hattori M, Õmura S (2003) Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol 21:526-531
26. Kieny MP, Excler JL, Girard M (2004) Research and development of new vaccines against infectious diseases. Am J Public Health 94:1931-1935
27. Kraus CH (2008) Low hanging fruit in infectious disease drug development. Curr Opin Microbiol 11:434-438
28. Kyrpides NC (2009) Fifteen years of microbial genomics: meeting the challenges and fulfilling the dream. Nat Biotechnol 27:627-632
29. Lagesen KW, Ussery DW, Wassenaar TM (2010) Genome update: the 1000th genome-cautionary tale. Microbiology 156:603-608
30. Lefevre F, Robe P, Jarrin C, Ginolhac A, Zago C, Auriol D, Vogel TM, Simonet P, Nalin R (2008) Drugs from hidden bugs: their discovery via untapped resources. Res Microbiol 159:153-161
31. Lynch AS, Robertson GT (2008) Bacterial and fungal biofilm infections. Ann Rev Med 59:415-428
32. Martin JF, Demain AL (1980) Control of antibiotic biosynthesis. Microbiol Rev 44:230-251
33. Menzella HG, Ralph RR, Carney JR, Chandran SS, Reisinger SJ, Patel KD, Hopwood DA, Santi D (2005) Combinatorial polyketide biosynthesis by de novo design and rearrangement of modular polyketide synthase genes. Nat Biotechnol 23:1171-1176
34. Moy TI, Ball AR, Anklesaria G, Lewis K, Ausubel FM (2006) Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A 103:10414-10419
35. Nikaido H (2009) Multidrug resistance in bacteria. Ann Rev Biochem 78:119-146
36. Ohnisi Y, Ishikawa J, Hara H, Suzuki H, Ikenoya M, Ikeda H, Yamashita A, Hattori M, Horinouchi S (2008) Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J Bacteriol 190:4050-4060
37. Oh T-J, Mo SJ, Yoon YJ, Sohng JK (2007) Discovery and molecular engineering of sugar-containing natural product biosynthetic pathways in actinomycetes. J Microbiol Biotechnol 17:1909-1921
38. Peláez F (2006) The historical delivery of antibiotics from microbial natural products-can history repeat? Biochem Pharmacol 71:981-990
39. Piel J (2006) Bacterial symbionts: prospects for the sustainable production of invertebrate-derived pharmaceuticals. Curr Med Chem 13:39-50
40. Reeves GA, Talavera D, Thornton JM (2009) Genome and proteome annotation: organization, interpretation and integration. J R Soc Interface 6:129-147
41. Report from the American Academy of Microbiology, 2009
42. Rigali S, Titgemeyer F, Barends S, Mulder S, Thomae AW, Hopwood DA, van Wezel GP (2008) Feast or famine: the global regulator DasR links nutrient stress to antibiotic production by Streptomyces. EMBO Rep 9:670-675
43. Sakharkar KR, Sakharkar MK, Chow V T K (2008) Biocomputational strategies for microbial drug target identification. In: Champney WS (ed) New antibiotic targets. Humana, Totowa, New Jersey, USA, pp 1-9
44. Spížek J, Tichý P (1995) Some aspects of overproduction of secondary metabolites. Folia Microbiol 40:43-50
45. Tahlan K, Ahn SA, Sing A, Bodnaruk TD, Willems AR, Davidson AR, Nodwell JR (2007) Initiation of actinorhodin export in Streptomyces coelicolor. Mol Microbiol 63:951-961
46. Udwary DW, Zeigler L, Asokar RN, Singan V, Lapidus A, Fenical W, Jensen PR, Moore BS (2007) Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinospora tropica. Proc Natl Acad Sci U S A 104:10376-10381
47. Vaněk Z, Hošťálek Z, Spížek J (1990) Overproduction of microbial products-facts and ideas. Biotechnol Adv 8:1-27
48. Walsh CF, Wright G (2005) Introduction: antibiotic resistance. Chem Rev 105:391-393
49. Walsh CT, Fischbach MA (2009) Squashing superbugs-the race for new antibiotics. Sci Amer Mag 301(1):44-51
50. Watve MG, Tickoo R, Jog MM, Rhole BD (2001) How many antibiotics are produced by the genus Streptomyces? Arch Microbiol 176:386-390